Use of fluorescent probes for detection of different types of CYP450-drug interactions.

被引:0
|
作者
Volak, LP [1 ]
Andrew, MM [1 ]
Tran, C [1 ]
Makings, LR [1 ]
Zlokarnik, G [1 ]
机构
[1] Aurora Biosci Corp, San Diego, CA USA
来源
FASEB JOURNAL | 2000年 / 14卷 / 08期
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
159
引用
收藏
页码:A1338 / A1338
页数:1
相关论文
共 50 条
  • [31] Detection of hidden explosives in different scenarios with the use of nuclear probes
    Nebbia, G
    Pesente, S
    Lunardon, M
    Moretto, S
    Viesti, G
    Cinausero, M
    Barbui, M
    Fioretto, E
    Filippini, V
    Sudac, D
    Nad, K
    Blagus, S
    Valkovic, V
    NUCLEAR PHYSICS A, 2005, 752 : 649C - 658C
  • [32] Recent advance of fluorescent probes for detection of drug-induced liver injury markers
    Dongqin Sun
    Zhenzhen Chen
    Jiali Hu
    Huajin Zeng
    Lingbo Qu
    Ran Yang
    ChineseChemicalLetters, 2022, 33 (10) : 4478 - 4494
  • [33] Recent advance of fluorescent probes for detection of drug-induced liver injury markers
    Sun, Dongqin
    Chen, Zhenzhen
    Hu, Jiali
    Zeng, Huajin
    Qu, Lingbo
    Yang, Ran
    CHINESE CHEMICAL LETTERS, 2022, 33 (10) : 4478 - 4494
  • [34] Prevalence of use of herbal therapies in adult cancer patients: Potential for herb-drug interactions.
    Citrin, DL
    Gupta, D
    Birdsall, TC
    Aslam, A
    Grutsch, JF
    Wodek, T
    Lis, CG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 549S - 549S
  • [35] Central Role of Cytochromes P450 (CYP) in Alcohol-Mediated Oxidative Stress and Alcohol-antiretroviral Therapy (ART) Interactions.
    Kumar, S.
    Jin, M.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2012, 7 : S72 - S73
  • [36] BIOL 115-Activity probes for profiling cytochrome P450 induction and drug interactions
    Wright, Aaron T.
    Cravatt, Benjamin F.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [37] Use of human CYP450-expressing bacteria for production of large quantities of drug metabolites
    Stewart, J
    Bauman, A
    Barnes, HJ
    Johnson, DA
    DRUG METABOLISM REVIEWS, 2002, 34 : 106 - 106
  • [38] Re: Pergolizzi et al. 2011: Exposure to potential CYP450 pharmacokinetic drug-drug interactions
    Nieminen, Tuija H.
    Hagelberg, Nora M.
    Saari, Teijo I.
    Gronlund, Juha
    Neuvonen, Pertti J.
    Olkkola, Klaus T.
    PAIN PRACTICE, 2012, 12 (01) : 81 - 82
  • [39] Mechanism of Drug-Drug Interactions Mediated by Human Cytochrome P450 CYP3A4 Monomer
    Denisov, Ilia G.
    Grinkova, Yelena V.
    Baylon, Javier L.
    Tajkhorshid, Emad
    Sligar, Stephen G.
    BIOCHEMISTRY, 2015, 54 (13) : 2227 - 2239
  • [40] Tunable fluorescent probes for selective detection of copper(II) and sulphide with completely different modes
    Zhao, Yuan-Chao
    Chen, Chong
    Chen, Biao
    Wang, Pei-Yi
    Wu, Zhi-Bing
    Li, Hu
    Song, Bao-An
    Yang, Song
    SENSORS AND ACTUATORS B-CHEMICAL, 2017, 241 : 168 - 173